Seeing Is Believing
APLS is currently covered by 15 analysts with an average potential upside of $17.11 (42.39%) backed by displayed 93 price targets and 145 ratings.
Analysts average stock forecasts to be materialized ratio is 80.6% with an average time for these price targets to be met of 244.17 days.
Highest price target for APLS is 93, Lowest price target is 24, average price target is 58.5.
Most recent stock forecast was given by MADHU KUMAR from GOLDMAN on 09-Nov-2023. First documented stock forecast 04-Dec-2017.
Currently, out of the existing stock ratings of APLS - 57 which are a Buy (79.17%), 15 which are a Hold (20.83%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
74
$23.7 (47.12%)
91
22 days ago
5/6 (83.33%)
$17.78 (52.25%)
373
Buy
93
$42.7 (84.89%)
29 days ago
0/7 (0%)
$52.79 (84.80%)
Buy
63
$12.7 (25.25%)
60
1 months ago
4/7 (57.14%)
$21.72 (48.53%)
436
Hold
46
$-4.3 (-8.55%)
43
1 months 19 days ago
5/5 (100%)
$11.73 (30.03%)
63
Buy
70
$19.7 (39.17%)
54
1 months 25 days ago
17/19 (89.47%)
$23.35 (61.50%)
240
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?